• Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock
Editor's Pick

Trump picks Dr. Marty Makary as Food and Drug Administration commissioner

by November 23, 2024
written by November 23, 2024

President-elect Trump on Friday announced he is nominating Johns Hopkins School of Medicine professor Dr. Marty Makary for Food and Drug Administration (FDA) commissioner. 

‘I am very pleased to nominate Marty Makary MD, MPH, FACS, for FDA Commissioner,’ Trump said in a statement. ‘FDA has lost the trust of Americans, and has lost sight of its primary goal as a regulator. The Agency needs Dr. Marty Makary, a Highly Respected Johns Hopkins Surgical Oncologist and Health Policy Expert, to course-correct and refocus the Agency.’ 

Makary’s nomination comes after Trump nominated Robert F. Kennedy, Jr. to lead the Department of Health and Human Services (HHS) to ‘Make America healthy again.’

Trump said Makary will ‘work under the leadership of Robert F. Kennedy Jr. to, among other things, properly evaluate harmful chemicals poisoning our Nation’s food supply and drugs and biologics being given to our Nation’s youth, so that we can finally address the Childhood Chronic Disease Epidemic.’ 

Trump in his statement added that Makary, who was a Fox News medical contributor, is also a ‘member of the prestigious National Academy of Medicine’ and ‘has devoted his career to improving Medical Quality and lowering Hospital and Drug Costs for all Americans. In addition, Dr. Makary is an accomplished Professor at the Johns Hopkins School of Medicine and Johns Hopkins Carey Business School, and a leading advocate for Healthcare Transparency. He has authored more than 300 scientific articles and three New York Times bestselling books on Healthcare.

Trump called Makary a ‘pioneer in the fields of Public Health, Cancer Care, and Surgery, and a tireless voice for vulnerable populations. He is the recipient of the Nobility in Science Award from the National Pancreas Foundation and numerous teaching awards. Dr. Makary currently leads the Evidence-Based Medicine and Public Policy Research Group at Johns Hopkins.’

He added, ‘I am confident that Dr. Makary, having dedicated his career to High-Quality, Lower-Cost Care, will restore FDA to the Gold Standard of Scientific Research, and cut the bureaucratic red tape at the Agency to make sure Americans get the Medical Cures and Treatments they deserve.’

Trump made several other announcements Friday evening as he continues his transition, including Dr. Janette Nesheiwat as surgeon general, and Dr. Dave Weldon to head the U.S. Centers for Disease Control and Prevention (CDC). 

This post appeared first on FOX NEWS
0 comment
0
FacebookTwitterPinterestEmail

previous post
Trump picks Dr. Janette Nesheiwat as nation’s next surgeon general
next post
Trump will appoint ‘dozens’ of judges, experts say, despite Dems ramming through nominees in lame-duck session

related articles

Congress sends bill ending longest government shutdown in...

November 13, 2025

House advances bill to end government shutdown with...

November 13, 2025

White House provides Trump health update after MRI...

November 12, 2025

JD Vance hails Trump admin’s ‘bulldozer’ approach to...

November 12, 2025

Rick Scott calls Democrats ‘heartless’ as he pitches...

November 12, 2025

RNC gets day at Supreme Court to challenge...

November 12, 2025

DAVID MARCUS: The 3 issues driving far-left’s split...

November 12, 2025

Michelle Obama reveals ‘infuriating’ moment on Air Force...

November 12, 2025

Longest government shutdown in history nears likely end...

November 12, 2025

Trump makes formal request to Israeli president to...

November 12, 2025
Enter Your Information Below To Receive Free Trading Ideas, Latest News, And Articles.


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Latest News

  • The dollar index fell to a new annual low on Wednesday

    August 23, 2024
  • New national poll reveals approval ratings for Biden, Trump amidst transition

    December 18, 2024
  • Morning Glory: Defining competence down

    August 1, 2024
  • Coca-Cola dodges after Trump says soda will switch back to cane sugar

    July 18, 2025
  • Eli Lilly’s tirzepatide injection results could trigger another bull run: Here’s why

    August 1, 2024

Popular Posts

  • 1

    Secret Service admits leaning on ‘state and local partners’ after claim it ignored Trump team’s past requests

    July 21, 2024
  • 2

    Five more House Democrats call on Biden to drop out, third US senator

    July 19, 2024
  • 3

    Forex Profit Calculator: Maximize Your Trading Potential

    July 10, 2024
  • 4

    Elon and Vivek should tackle US funding for this boondoogle organization and score a multimillion dollar win

    December 4, 2024
  • 5

    District judges’ orders blocking Trump agenda face hearing in top Senate committee

    April 2, 2025

Categories

  • Economy (829)
  • Editor's Pick (6,754)
  • Investing (634)
  • Stock (949)

Latest Posts

  • Morning Glory: Justice Gorsuch takes his case public

    August 6, 2024
  • SCOTUS to hear straight woman’s discrimination case that could reshape employment law

    February 26, 2025
  • Senate unanimously approves $25,000 tax break for tipped workers

    May 21, 2025

Recent Posts

  • In battle to define Harris, Trump hits Democratic coup, ad calls her ‘dangerously liberal’

    July 31, 2024
  • Trump names latest White House staff picks as Jan. 20 inauguration approaches

    January 5, 2025
  • ROBERT MAGINNIS: 9 signs Beijing’s Taiwan invasion may be imminent

    May 31, 2025

Editor’s Pick

  • Elon Musk, Vivek Ramaswamy to lead Trump’s Department of Government Efficiency

    November 13, 2024
  • Trump says Iran would ‘like to talk’ about dialing down Israel-Iran conflict

    June 16, 2025
  • Republican AGs double down on Biden administration lawsuits as president prepares to leave office

    January 9, 2025
  • About us
  • Contacts
  • Privacy Policy
  • Terms & Conditions

Disclaimer: moneyrisetoday.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2025 moneyrisetoday.com | All Rights Reserved

Money Rise Today – Investing and Stock News
  • Economy
  • Editor’s Pick
Money Rise Today – Investing and Stock News
  • Investing
  • Stock